Sustained use of nonsteroidal anti-inflammatory drugs, rather than cumulative dose, is associated with reduced risk for ...

For acute low back pain, there is moderate-certainty evidence that nonsteroidal anti-inflammatory drugs are an effective treatment.

Nonsteroidal anti-inflammatory drug use for over 2 years was associated with a lower risk for dementia, especially ...

The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on Monday. Approval of the topical aryl hydrocarbon receptor agonist was ...

Nonsteroidal anti-inflammatory drug use was associated with lower dementia risk for long-term users and with elevated risk for short-term and intermediate-term use. HealthDay News — Long-term ...

HealthDay News — In a clinical guideline issued by the American College of Physicians (ACP) and published online March 18 in the Annals of Internal Medicine, recommendations are presented for the ...

The U.S. Food and Drug Administration (USFDA) approved Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy (DMD) in patients six years of age and older.

There are some 20 traditional nonsteroidal anti-inflammatory drugs or NSAIDs, including aspirin, ibuprofen (Advil and Motrin), naproxen (Aleve), indomethacin (Indocin), and piroxicam (Feldene).

The nonsteroidal anti-inflammatory drug (NSAID) flunixin meglumine has been approved by the FDA for fever associated with ...

Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...